ASCO PREVIEW: Roche, BMS, Amgen immunotherapy drugs to be focal point
This article was originally published in Scrip
Executive Summary
Scientists have been trying to develop drugs that give the immune system a boost to battle cancer for decades, but the research has resulted in far more failures than victories.